XMAD
CBAV
Market cap954mUSD
Oct 30, Last price
53.20EUR
1D
-1.12%
1Q
-10.74%
Jan 2017
460.00%
IPO
126.38%
Name
Clinica Baviera SA
Chart & performance
P/E
20.28
P/S
2.83
EPS
2.62
Vol. 1Y
27.21%
Shs. 5Y
0.42%
Rev. 5Y
19.74%
Div Yld LY
2.95%
Div Yld TTM
2.95%
Revenues
302m
+14.90%
Net income
42m
+4.62%
CFO
76m
+21.87%
Dividend
Jun 10, 20261.568 EUR/sh
Earnings
Nov 18, 2026
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.
Related entities
Parent
AIER EYE INTERNATIONAL EUROPE S.L.
Subsidiaries
CARE Vision Germany GmbH
Key people
Virgilio Leal Espi
Chief Financial Officer
Marisa Tuset Sabater
Chief Operating Officer, Spain · since 2021
Fernando Jose Carrero Bosch
Chief Human Resources Officer · since 2021
Eduardo Baviera Sabater
Chief Executive Officer, Executive Director · since 2017
Juan Garcia Morinigo
Chief Internal Audit Officer · since 2021
Luis Gravalos Soria
Country Manager, Germany and United Kingdom · since 2024
Antonio Munoz Sanchez De Mol
Chief Digital Transformation Officer
Belen Olaguibel Lopez Bosch
Corporate Director · since 2024
Antonio Peral Ortiz De La To
Non-Member Secretary of the Board · since 2020
Chairman of the Board, Proprietary Director · since 2022
Proprietary Director · since 2017
Proprietary Director · since 2017
Yongmei Zhang
Proprietary Director · since 2017
Carolina Martinez-caro
Independent Director · since 2024
Independent Director · since 2019
Headquarters & legal address
PASEO DE LA CASTELLANA 20 BAJO
Madrid 28046
ES
Madrid 28046
ES
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||